In 2023, Slovakia leads global blood and blood-forming organs medicine sales in terms of total sales with 12.7%, reflecting a minor decline of 0.93%. Germany saw significant growth of 5.41%, reaching 10.8%, followed by Estonia at 10.5%, which slightly dipped by 0.74%. Sweden, at 10.4%, had moderate increases. Portugal and Chile showed upward trends of 2.01% and 5.29%, respectively. Australia saw modest growth at 1.41%, leading to a 5.9% share.
Future trends to monitor include emerging market demands in Asia and technological advancements in biopharmaceuticals that could influence global sales distribution and market dynamics.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 7 Countries | Percent of Total Sales | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Slovakia | 12.7 | 2023 | +1.63% | -0.93% | View data |
| 2 | 2 Germany | 10.8 | 2023 | +3.85% | +5.41% | View data |
| 3 | 3 Estonia | 10.5 | 2023 | -1.87% | -0.74% | View data |
| 4 | 4 Sweden | 10.4 | 2023 | +0.97% | +1.4% | View data |
| 5 | 5 Portugal | 9.5 | 2023 | 0% | +2.01% | View data |
| 6 | 6 Chile | 6.6 | 2023 | +4.76% | +5.29% | View data |
| 7 | 7 Australia | 5.9 | 2023 | 0% | +1.41% | View data |
